Search results for "manufacturing"
Article
In-person seminar: Manufacture of sterile medicinal products
Are you developing a Contamination Control Strategy? Join us for a free in-person seminar focused on applications at the end of the bulk drug substance workflow including drug product applicat…
Article
Get a strong start in oligonucleotide manufacturing
Oligonucleotide therapeutics hold incredible promise. How can you harness their full potential? When starting process development, you need to know where to focus, and you need a scalable a…
Article
Oligonucleotide Development and Manufacturing Workflow
Click here to view >>
Learn more on key considerations when setting up an oligonucleotide workflow with this infographic.
Article
Increase Efficiency in Your Manufacturing with the Right Buffer Management Strategy
Click here to sign up >>
Date: Wednesday, January 27, 2021
Time: 10:00 AM Eastern Standard Time
Register for our free webinar, where we compare traditional buffer preparation with outsou…
Resource
Protein A Fiber Chromatography from Research to Scale-up and Manufacturing of Monoclonal Antibodies
The new Protein A fiber chromatography format allows for quick purification of many samples because of its short cycle times. This makes the pre-packed, small-scale Protein A fiber unit a versatile …
Article
Optimized Process Efficiency in Upstream Manufacturing
Process efficiency is a key goal for biopharmaceutical production. Click here to learn how faster cell-line development, real-time analytics, and other approaches can be used to create a flexi…
Poster
Scaling In-Line Buffer Preparation from Process Development to Manufacturing
At the same time, process changes in biomanufacturing require downscaling models. This poster demonstrates how ÄKTA™ avant can be used to replicate the BioProcess™ IC System in bench scale.
Article
Manufacturing of Viral Vectors
Viruses are infectious agents that can only replicate inside of living cells. This trait is used by molecular biologists for the delivery of genetic materials into cells. Viral vectors are also explor…
Article
Regulatory Challenges in the QbD Paradigm
Regulators also must offer more flexibility regarding manufacturing changes and application supplements based on science and risk assessment, so that limited resources on both the industry and regulat…
Article
Maximum Output Starts with Optimized Upstream Processing
Significant growth in the development and manufacturing of biologics—from traditional recombinant proteins and monoclonal antibodies (mAbs) to advanced multispecifics, antibody-drug conjugates, viral …